{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:15:56Z","timestamp":1791918956398,"version":"4.3.4"},"reference-count":68,"publisher":"Wiley","issue":"14","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pretreatment prognostic factors in newly diagnosed osteosarcoma are important for clinical management and stratifying patients in clinical trials. Such factors include the presence of metastases, primary tumor size, and site. Factors surrounded by controversy include pathological fracture, histologic subtype, and P\u2010glycoprotein expression. No prognostic tumor biomarker has been established. We performed a systematic review with the aim to compile available evidence for pretreatment prognostic factors and define optimal cut\u2010off values for patient stratification or further validation in the upcoming European FOSTER\u2010CabOS trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Predefined search terms were used to search PubMed, Web\u2010of\u2010science, and Embase for all studies investigating pretreatment prognostic factors in newly diagnosed osteosarcoma patients published 2000\u20132023. After applying strict inclusion and exclusion criteria, 49 papers were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found 14 factors investigated in at least two separate studies or in a single study using one discovery and at least one validation cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We confirmed the prognostic value of patient age, presence of metastasis, tumor size, and site (axial vs. appendicular). Future studies of these factors should focus on specific patient populations and defining optimal cut\u2010off values. Although serum level of alkaline phosphatase and lactate dehydrogenase were associated with outcome, it remains unclear if they are independent of other prognostic factors. The prognostic value remains unclear for sex, pathological fracture, histologic subtype, and P\u2010glycoprotein expression. We could not establish any new prognostic biomarker. However, circulating tumor DNA in plasma and the G1\/G2 RNA signature in diagnostic tumor biopsies show promise and will be further validated in the upcoming FOSTER\u2010CabOS trial.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/cam4.71044","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T02:15:26Z","timestamp":1752718526000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prognostic Factors in Newly Diagnosed High\u2010Grade Osteosarcoma\u2014A Systematic Review"],"prefix":"10.1002","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4144-5957","authenticated-orcid":false,"given":"Elisa","family":"Tirtei","sequence":"first","affiliation":[{"name":"Department of Pediatric Oncology Regina Margherita Children's Hospital  Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6499-8581","authenticated-orcid":false,"given":"Sascha Wilk","family":"Michelsen","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescence Medicine, Clinic for Pediatric Oncology and Hematology University Hospital Rigshospitalet  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8519-8906","authenticated-orcid":false,"given":"Lianne M.","family":"Haveman","sequence":"additional","affiliation":[{"name":"Princess Maxima Center for Pediatric Oncology  Utrecht the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1875-9563","authenticated-orcid":false,"given":"Cristina","family":"Meazza","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit Fondazione IRCCS Istituto Nazionale dei Tumori  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana F.","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Pediatric Department Portuguese Institute of Oncology of Lisbon  Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Rasool","sequence":"additional","affiliation":[{"name":"UCL Cancer Institute  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3406-6705","authenticated-orcid":false,"given":"Emanuela","family":"Palmerini","sequence":"additional","affiliation":[{"name":"Osteoncology, Bone and Soft Tissue Tumors and Innovative Therapies IRCCS Istituto Ortopedico Rizzoli  Bologna Italy"},{"name":"Miller School of Medicine University of Miami  Miami Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5576-0135","authenticated-orcid":false,"given":"Will","family":"Wilson","sequence":"additional","affiliation":[{"name":"Cancer Research UK and UCL Cancer Trials Centre  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1827-8903","authenticated-orcid":false,"given":"Nathalie","family":"Gaspar","sequence":"additional","affiliation":[{"name":"Department of Oncology for Child and Adolescent Gustave Roussy Cancer Campus  Villejuif France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8328-0260","authenticated-orcid":false,"given":"Sandra J.","family":"Strauss","sequence":"additional","affiliation":[{"name":"Department of Oncology UCL Cancer Institute  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4232-4658","authenticated-orcid":false,"given":"Andri","family":"Papakonstantinou","sequence":"additional","affiliation":[{"name":"Department of Oncology\u2010Pathology Karolinska Institutet  Stockholm Sweden"},{"name":"Department of Breast Cancer, Endocrine Tumors and Sarcoma Karolinska Comprehensive Cancer Center, Karolinska University Hospital  Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1333-2912","authenticated-orcid":false,"given":"Fredrik","family":"Baecklund","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Karolinska University Hospital  Stockholm Sweden"},{"name":"Department of Molecular Medicine and Surgery, Rare Disease Group Karolinska Institutet  Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the FOSTER Consortium (Fight OsteoSarcoma Through European Research), work package 4 on trials in newly diagnosed osteosarcoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2020.151654"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.11.027"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34131"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.09.036"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.03.141"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.5301\/tj.5000636"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcped.2023.100029"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.08.1995"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-0284-9_15"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24868"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101349"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21724"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1023\/a:1011636912674"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOSGlobal\u2010D\u201022\u201000009"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2015.05.001"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12891\u2010018\u20102217\u20101"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030486"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21843"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885\u2010018\u20104487\u20102"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12957\u2010016\u20100889\u20102"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00402\u2010008\u20100714\u20107"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032\u2010013\u20100624\u20106"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743\u20107563.2012.01560.x"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22293"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1089\/jayao.2013.0012"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.01.142"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1148480"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30070511"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/2309499019896662"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000911"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.24045"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.08.132"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20986"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.7150\/jca.42341"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5276"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477\u20107819\u201010\u201037"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.15570"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00827"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.24809"},{"issue":"1","key":"e_1_2_10_42_1","first-page":"49","article-title":"Pathologic Fracture in Osteosarcoma: Prognostic Importance and Treatment Implications","volume":"84","author":"Scully S. P.","year":"2002","journal-title":"Journal of Bone and Joint Surgery. American Volume"},{"issue":"6","key":"e_1_2_10_43_1","first-page":"1459","article-title":"May P\u2010Glycoprotein Status Be Used to Stratify High\u2010Grade Osteosarcoma Patients? Results From the Italian\/Scandinavian Sarcoma Group 1 Treatment Protocol","volume":"29","author":"Serra M.","year":"2006","journal-title":"International Journal of Oncology"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.03.144"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003086\u2010200004000\u201000003"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.7776"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.14.2685"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008\u20105472.CAN\u201020\u20104189"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1022"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.1.5"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21263"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17811"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11999\u2010014\u20103910\u20105"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/030089160409000507"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.12.006"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416\u2010018\u20100212\u20109"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.03.002"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S340723"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12094\u2010015\u20101467\u20108"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.0534"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11546"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13148"},{"key":"e_1_2_10_63_1","unstructured":"R.vanEwijk L.Hiemcke\u2010Jiwa J. Y.Hehir\u2010wa et\u00a0al. \u201cValidation of a Focused Gene Expression Signature to Stratify Osteosarcoma in an Independent Pediatric and Adolescent Cohort: A Way Forward For Future Trials? \u201d [conference abstract] presented at Connective Tissue Oncology Society (CTOS) Annual Meeting Dublin Ireland November 1\u20134 2023."},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41413\u2010023\u201000246\u2010z"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22912"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1331193"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.11530"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078\u20100432.CCR\u201024\u20100101"},{"key":"e_1_2_10_69_1","unstructured":"E.Rubin M.Krailo M.Le Deley et\u00a0al. \u201cDevelopment and Mission of the Harmonization International Bone Sarcoma Consortium (HIBISCUS) \u201d [conference abstract] presented at Connective Tissue Oncology Society (CTOS) Annual Meeting Dublin Ireland November 1\u20134 2023. Poster 69."}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.71044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T06:02:45Z","timestamp":1754460165000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.71044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":68,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1002\/cam4.71044"],"URL":"https:\/\/doi.org\/10.1002\/cam4.71044","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"value":"2045-7634","type":"print"},{"value":"2045-7634","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2024-11-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e71044"}}